|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||5.16 - 5.54|
|52-week range||2.61 - 10.91|
|Beta (5Y monthly)||1.14|
|PE ratio (TTM)||N/A|
|Earnings date||18 Feb 2021 - 22 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||14 Jul 2008|
|1y target est||10.25|
In cavernous cold-storage warehouses at Amsterdam's Schiphol Airport, KLM workers are gearing up for a surge next year in COVID-19 vaccine cargos that will need to be flown around the world at ultra-low temperatures. A major hub for pharmaceutical products, Schiphol has already handled some of the vaccines being used in trials and KLM's boss is confident its "cold chain" operations will cope with the influx of cargos as mass inoculations start in earnest. "The short and sweet of it is, yes, we're ready," KLM Chief Executive Pieter Elbers told Reuters.
A Biden presidency transition on the horizon, vaccine news and hopes of global economic recovery lift markets.
The French government will continue to support airline company Air France-KLM if necessary, government spokesman Gabriel Attal said on Wednesday. Attal, holding a news conference after a cabinet meeting, was asked about a report that Air France-KLM was discussing plans to raise another 6 billion euros ($7.1 billion) from its two government shareholders and other investors. The company received 10.4 billion euros in state-backed bailouts from France and the Netherlands earlier this year to help it cope with the impact of the coronavirus pandemic.